These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 31166204

  • 21. Meta-analysis Comparing the Efficacy of Dobutamine Versus Milrinone in Acute Decompensated Heart Failure and Cardiogenic Shock.
    Biswas S, Malik AH, Bandyopadhyay D, Gupta R, Goel A, Briasoulis A, Fonarow GC, Lanier GM, Naidu SS.
    Curr Probl Cardiol; 2023 Aug; 48(8):101245. PubMed ID: 35545181
    [Abstract] [Full Text] [Related]

  • 22. Vasopressors and Inotropes as Predictors of Mortality in Acute Severe Cardiogenic Shock Treated With the Impella Device.
    Rohm CL, Gadidov B, Ray HE, Mannino SF, Prasad R.
    Cardiovasc Revasc Med; 2021 Oct; 31():71-75. PubMed ID: 33309042
    [Abstract] [Full Text] [Related]

  • 23. Vasopressor and Inotrope Use in Canadian Emergency Departments: Evidence Based Consensus Guidelines.
    Djogovic D, MacDonald S, Wensel A, Green R, Loubani O, Archambault P, Bordeleau S, Messenger D, Szulewski A, Davidow J, Kircher J, Gray S, Smith K, Lee J, Marc Benoit J, Howes D.
    CJEM; 2015 Feb; 17 Suppl 1():1-16. PubMed ID: 26067924
    [No Abstract] [Full Text] [Related]

  • 24. Vasopressor and inotrope use in Canadian emergency departments: evidence based consensus guidelines.
    Djogovic D, MacDonald S, Wensel A, Green R, Loubani O, Archambault P, Bordeleau S, Messenger D, Szulewski A, Davidow J, Kircher J, Gray S, Smith K, Lee J, Benoit JM, Howes D.
    CJEM; 2015 Jan; 17(1):1-2. PubMed ID: 25961083
    [No Abstract] [Full Text] [Related]

  • 25. Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock. A prospective, randomized pilot study.
    Levy B, Perez P, Perny J, Thivilier C, Gerard A.
    Crit Care Med; 2011 Mar; 39(3):450-5. PubMed ID: 21037469
    [Abstract] [Full Text] [Related]

  • 26. Are vasopressors useful in toxin-induced cardiogenic shock?
    Skoog CA, Engebretsen KM.
    Clin Toxicol (Phila); 2017 Apr; 55(4):285-304. PubMed ID: 28152638
    [Abstract] [Full Text] [Related]

  • 27. Epinephrine Versus Norepinephrine for Cardiogenic Shock After Acute Myocardial Infarction.
    Levy B, Clere-Jehl R, Legras A, Morichau-Beauchant T, Leone M, Frederique G, Quenot JP, Kimmoun A, Cariou A, Lassus J, Harjola VP, Meziani F, Louis G, Rossignol P, Duarte K, Girerd N, Mebazaa A, Vignon P, Collaborators.
    J Am Coll Cardiol; 2018 Jul 10; 72(2):173-182. PubMed ID: 29976291
    [Abstract] [Full Text] [Related]

  • 28. [Modern drug therapy in cardiovascular intensive care medicine].
    Lemm H, Dietz S, Janusch M, Buerke M.
    Internist (Berl); 2015 Jun 10; 56(6):702, 704-8, 710-2. PubMed ID: 26054838
    [Abstract] [Full Text] [Related]

  • 29. Levosimendan as rescue therapy in severe cardiogenic shock after ST-elevation myocardial infarction.
    Greif M, Zwermann L, Reithmann C, Weis M.
    Acute Card Care; 2008 Jun 10; 10(3):185-90. PubMed ID: 18972629
    [Abstract] [Full Text] [Related]

  • 30. Pharmacotherapy update on the use of vasopressors and inotropes in the intensive care unit.
    Jentzer JC, Coons JC, Link CB, Schmidhofer M.
    J Cardiovasc Pharmacol Ther; 2015 May 10; 20(3):249-60. PubMed ID: 25432872
    [Abstract] [Full Text] [Related]

  • 31. Cardiogenic shock.
    Rackley CE, Russell RO, Mantle JA, Rogers WJ.
    Cardiovasc Clin; 1981 May 10; 11(3):15-24. PubMed ID: 7214388
    [Abstract] [Full Text] [Related]

  • 32. Is it time to reposition vasopressors and inotropes in sepsis?
    Rudis MI, Basha MA, Zarowitz BJ.
    Crit Care Med; 1996 Mar 10; 24(3):525-37. PubMed ID: 8625645
    [Abstract] [Full Text] [Related]

  • 33. Nonischemic Causes of Cardiogenic Shock.
    Wilcox SR.
    Emerg Med Clin North Am; 2019 Aug 10; 37(3):493-509. PubMed ID: 31262417
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Treatment of cardiogenic shock with the Ca2+ sensitizer levosimendan].
    Zobel C, Reuter H, Schwinger RH.
    Med Klin (Munich); 2004 Dec 15; 99(12):742-6. PubMed ID: 15599685
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.